ACTIVE SUBSTANCE / INN

SOYBEAN OIL

Brand name(s): INTRALIPID 20%, INTRALIPID 10%, LIPOSYN II 10%, SMOFLIPID 20%, NUTRILIPID 20%, NUTRILIPID 10%, LIPOSYN III 20%, INTRALIPID 30%, LIPOSYN III 30%, SOYACAL 20%
FDA LISTED
PRESCRIPTION
DISCONTINUED
NDA018997
NDA018449
ACTIVE SUBSTANCE
Soybean Oil
REGULATORS
FDA
SPONSORS / MAH
HOSPIRA, ALPHA THERA, FRESENIUS KABI USA
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
INTRALIPID 30%NDA019942FRESENIUSPrescription
LIPOSYN III 30%NDA020181HOSPIRADiscontinued
LIPOSYN III 20%NDA018970HOSPIRADiscontinued
LIPOSYN II 10%NDA018997HOSPIRADiscontinued
INTRALIPID 20%NDA018449FRESENIUSPrescription
SMOFLIPID 20%NDA207648FRESENIUS KABI USAPrescription
SOYACAL 20%NDA018786ALPHA THERADiscontinued
NUTRILIPID 10%NDA019531B BRAUNDiscontinued
NUTRILIPID 20%NDA019531B BRAUNPrescription
INTRALIPID 10%NDA017643FRESENIUSDiscontinued

FULL INTELLIGENCE ON SOYBEAN OIL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →